HSE Decision on Skyclarys for Friedreich's Ataxia | Cork News

Families across Ireland are holding their breath as the HSE prepares to decide whether to cover the only approved treatment for Friedreich’s Ataxia—a devastating disease affecting around 200 people—by August 25th. The initial rejection of coverage sent shockwaves through patient communities, especially after promises from the Taoiseach that all possible efforts would be made to secure approval. Grief-stricken parents like Craig Coady, who lost his son Rory and battles for his other son Paudie, are joined by political leaders including Mary Lou McDonald and Michael Collins, demanding transparency and urgent action. With lives hanging in the balance, the clock is ticking—and the pressure is mounting on the HSE to make a decision that acknowledges the life-or-death stakes for patients like Emma OShea. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6b27c1d89bf80484